Intensification of Human Insulin Therapy with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Dzida, Grzegorz J.
Gajda, Piotr
Masierek, Malgorzata
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-20-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20-PUB
引用
收藏
页数：1
相关论文
共 50 条
  • [31] SGLT2 Inhibitors for the Prevention of Kidney Failure in Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (07): : 663 - 664
  • [32] Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus
    Peppa, Melpomeni
    Manta, Aspasia
    Mavroeidi, Ioanna
    Asimakopoulou, Athina
    Syrigos, Alexandros
    Nastos, Constantinos
    Pikoulis, Emmanouil
    Kollias, Anastasios
    PHARMACEUTICS, 2023, 15 (11)
  • [33] The Kidney Effects of the SGLT2 Inhibitors on the Japanese Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease
    Kobayashi, Kazuo
    Toyoda, Masao
    Hatori, Nobuo
    Sakai, Hiroyuki
    Furuki, Takayuki
    Tamura, Kouichi
    Miyakawa, Masaaki
    DIABETES, 2019, 68
  • [34] SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
    Thomas, Merlin C.
    Neuen, Brendon L.
    Twigg, Stephen M.
    Cooper, Mark E.
    Badve, Sunil, V
    ENDOCRINE CONNECTIONS, 2023, 12 (08)
  • [35] THE EFFICACY AND SAFETY OF THE SGLT2 RECEPTOR INHIBITORS IN TRIPLE THERAPY IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES
    Abreu Lomba, A.
    Bedoya Joaqui, V.
    Osorio Toro, L. M.
    Munoz Lombo, J. P.
    Salgado Cifuentes, C. A.
    Campo Rivera, N.
    Casanova Valderrama, M. E.
    Carvajal Ortiz, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A138 - A138
  • [36] Effects of SGLT2 inhibitors as an add-on therapy to metformin on index of cardiac electrophysiological balance in type 2 diabetes mellitus patients
    Ziyrek, Murat
    Donmez, Esra
    Ozcan, Sevgi
    Ince, Orhan
    Sahin, Irfan
    Okuyan, Ertugrul
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 : S100 - S100
  • [37] SGLT2 INHIBITORS AND KIDNEYS: MECHANISMS AND MAIN EFFECTS IN DIABETES MELLITUS PATIENTS
    Salukhov, Vladimir V.
    Khalimov, Yurii Sh
    Shustov, Sergey B.
    Popov, Sergey, I
    DIABETES MELLITUS, 2020, 23 (05): : 475 - 491
  • [38] SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
    Christoph Wanner
    Nikolaus Marx
    Diabetologia, 2018, 61 : 2134 - 2139
  • [39] SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus
    Misra, Monika
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (03) : 317 - 327
  • [40] SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus
    Ghosh, Raktim Kumar
    Ghosh, Samhati Mondal
    Chawla, Shalini
    Jasdanwala, Sarfaraz Abdeli
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (04): : 457 - 463
12345